Hyperspectral imaging for evaluation of microcirculation in the resuscitation room

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00024047

Enrollment

Registered

2021-09-23

Start date

2021-10-31

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T07 T79.4 R57.1

Interventions

Group 1: Control group: patients in the resuscitation room with guideline-based diagnostics and therapy Group 2: Intervention Group: Patients in the resuscitation room with guideline-based diagnostics

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Consent of the resusctiation room leader (consultant in anesthesiology or surgery) after the patient has been handed over by the accompanying emergency physician - Age = 18 years

Exclusion criteria

Exclusion criteria: - Refusal to participate in the study - Inmates - Active or completed suicide attempt

Design outcomes

Primary

Measure	Time frame
Impact of hyperspectral measurement of a hand on treatment time in the resuscitation room	—

Secondary

Measure	Time frame
1. hyperspectral measurement of various microcirculatory parameters (tissue oxygenation, near-infrared perfusion index, tissue hemoglobin index, tissue water index) on both hands in patients treated in the shock room. 2. comparison of tissue oxygenation, near-infrared perfusion index, tissue hemoglobin index, tissue water index in hemodynamically stable patients with patients with hemodynamic instability (shock) 3. comparison of tissue oxygenation, near-infrared perfusion index, tissue hemoglobin index, tissue water index in different types of shock (hemorrhagic, neurogenic, cardiogenic, obstructive, distributive) 4. correlation of microcirculatory parameters with morbidity and mortality (ISS score, SOFA score) 5. correlation of various biomarkers (e.g., lactate, C-reactive protein, interleukin-6, hemoglobin, procalcitonin, myoglobin) with hyperspectrally recorded microcirculatory parameters 6. correlation of hyperspectrally recorded microcirculatory parameters and prehospital fluid balance 7. correlation of hyperspectrally recorded microcirculatory parameters and intensive care unit length of stay and hospital length of stay 8. correlation of tissue oxygenation, near-infrared perfusion index, tissue hemoglobin index, tissue water index to distinguish whether shock is present or not.	—

Measure

Time frame

1. hyperspectral measurement of various microcirculatory parameters (tissue oxygenation, near-infrared perfusion index, tissue hemoglobin index, tissue water index) on both hands in patients treated in the shock room. 2. comparison of tissue oxygenation, near-infrared perfusion index, tissue hemoglobin index, tissue water index in hemodynamically stable patients with patients with hemodynamic instability (shock) 3. comparison of tissue oxygenation, near-infrared perfusion index, tissue hemoglobin index, tissue water index in different types of shock (hemorrhagic, neurogenic, cardiogenic, obstructive, distributive) 4. correlation of microcirculatory parameters with morbidity and mortality (ISS score, SOFA score) 5. correlation of various biomarkers (e.g., lactate, C-reactive protein, interleukin-6, hemoglobin, procalcitonin, myoglobin) with hyperspectrally recorded microcirculatory parameters 6. correlation of hyperspectrally recorded microcirculatory parameters and prehospital fluid balance 7. correlation of hyperspectrally recorded microcirculatory parameters and intensive care unit length of stay and hospital length of stay 8. correlation of tissue oxygenation, near-infrared perfusion index, tissue hemoglobin index, tissue water index to distinguish whether shock is present or not.

—

Countries

Germany

Contacts

Public ContactStephan Katzenschlager

Universitätsklinikum Heidelberg

Stephan.Katzenschlager@med.uni-heidelberg.de+4962215639683

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026